Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.
By Guo-Kun Wang, Jia-qi Zhu, Jun-Tao Zhang, Qing Li, Yue Li, Jia He, Yong-wen Qin, Qing Jing. European Heart Journal, 2010
1,221 citations recorded by the source corpus.
Subfields: Cancer Research, Cardiology and Cardiovascular Medicine, Immunology
View Paper: https://www.semanticscholar.org/paper/a174a1b5ebd6770de6f2b28a3358b74dc7ce373e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications (2020, positive): “The level of exosomal microRNAs associated with cardiovascular diseases including miR-499, miR-133, miR-208, miR-192, miR-194, miRNA-34a is up-regulated in patients with acute myocardial infarction and heart failure, 85–88 which provides a strong basis for their use as a diagnostic marker.”
- Comparing the MicroRNA Spectrum between Serum and Plasma (2012, background): “Examples of this include the associations of miR-141 with prostate cancer, miR-499 with myocardial infarction, and miR-122 with drug-induced liver injury [3–7].”
- microRNA as Biomarkers and Diagnostics (2016, background): “…system disorders (Mehler and Mattick, 2007), cardiovascular disorders (van Rooij et al., 2006a; Hebert and De Strooper, 2009; Ai et al., 2010; Wang et al., 2010), muscular disorders (Eisenberg et al., 2007), diabetes, and other diseases (Nielsen et al., 2012), which implies that utilizing…”
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarction (2010, background): “Finally, two very recent studies have examined circulating miRNAs in patients with acute MI.(18,19) In light of these findings, it has been hypothesized that at least in some pathological conditions, miRNAs in the systemic circulation may reflect tissue damage and, for this reason, they may be regar”
- miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis (2020, background): “found that miR-208a had the highest accuracy in diagnosing AMI, with levels significantly increasing as early as 1 h post-occlusion in 90% of investigated AMI patients and in 100% AMI patients within 4 h [208].”